Advanced search
Log in
Forgot password ?
Remember
Or log in with
Google
Twitter
Facebook
Apple
Sign up
Email Registration
Or log in with
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
Markets
Equities
Top Capitalization
United States
North America
Europe
Asia
Middle East
Sector Research
Earnings Calendar
Equities Analysis
Most popular
ALPHABET INC.
MICROSOFT CORPORATION
AMAZON.COM, INC.
TESLA, INC.
APPLE INC.
NVIDIA CORPORATION
META PLATFORMS, INC.
Indexes
Homepage
Rankings
Europe
America
Asia
Africa
Index Analysis
Indexes News
S&P 500
DOW JONES
NASDAQ 100
TSX COMP
FTSE 100
DAX
CAC 40
EURO STOXX 50
Currency / Forex
Homepage
Rankings
Currency Cross Rate
Currency Converter
Forex Analysis
Currencies News
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
Commodities
Homepage
Energy
Precious metals
Agriculture
Industrial Metals
Livestock and Cattle
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
Cryptocurrencies
Homepage
Rankings
Charts
Analysis
News
BITCOIN
ETHEREUM
BINANCE COIN
SOLANA
CARDANO
FTX TOKEN
Interest Rates
Homepage
Developed Nations
Emerging Countries
ETFs Rates
ETF
Rankings and News
Advanced Search
News
All News
World
United States
Europe
North America
South America
Asia
Africa
Middle East
Emerging
Companies
All News
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Security Transactions
Earnings reports
New markets
New products
Corporate strategies
Legal risks
Share buybacks
Mergers and acquisitions
Call Transcripts
Guidance
Indexes
Currency / Forex
Commodities
Cryptocurrencies
ETF
Interest Rates
Economy
Themes
Asset Management
Activism
Climate and ESG
Cybersecurity
Geopolitics
Central Banks
Private Equity
Inflation
Business Leaders
Sectors
All our articles
Most Read News
Hot News
Analysis
All Analysis
Must Read
Equities
Indexes
Currencies
Commodities
Cryptocurrencies
Stock Trading Strategies
All
America
Europe
Asia
Our Shows
Shows
Must Watch
Satirical Cartoon
Today's Editorial
Crypto Recap
Stock Picks
All our stock picks
North America
Europe
Asia, Pacific
Portfolios
Virtual Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Watchlists
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Homepage
Quality stocks
Dividend Kings
Yield stocks
Trend-Following Stocks
Quality stocks at a reasonable price
ESG stocks
Investment Themes
Homepage
Cybersecurity
In Vino Veritas
Oligopolies
US Basketball
The Internet of Things
Adtechs
Rankings
Top Movers
Top Movers
Unusual volumes
New Historical Highs
New Historical Lows
Long Term
Top Fundamentals
Top Fundamentals
Sales growth
Earnings Growth
Profitability
Finances
Rankings Valuation
Rankings Valuation
P/E ratio
Enterprise value
Yield
Top Consensus
Top Consensus
Analyst Opinion
Target price
Estimates Revisions
Divergence
Top Technicals
Top RSI
Unusual volumes
GAPS
STIM
Breakouts
Trends
Volatility
Top ranking ESG
Top ranking ESG
Environnement
Social
Gouvernance
Rankings Coverage
Screeners
Stock Screener Home
Investment Themes
Hydrogen
Sin stocks
The Golden Age of Video Games
In Vino Veritas
Metaverse
Adtechs
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Low valuations
My Screeners
All my stocks
Watchlists
Virtual Portfolios
Tools
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Dynamic Chart
Earnings Calendar
Economic Calendar
Currency Converter
ProRealTime Trading
Our Services
Our subscriptions
Our Stock Picks
Stock Screener
Thematic Investment Lists
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Homepage
Equities
United States
Nyse
Johnson & Johnson
News
Summary
JNJ
US4781601046
JOHNSON & JOHNSON
(JNJ)
Add to my list
Report
Real-time Estimate Cboe BZX -
07:59:15 2023-06-08 pm EDT
160.70
USD
+0.27%
09:29a
Johnson & Johnson Releases its 2022 Health for Humanity Report and We All Belong, 2022 DEI Impact Review
AQ
09:12a
Johnson & Johnson Releases 2022 Health for Humanity Report Demonstrating Progress Against Goals
AQ
03:55a
Johnson & Johnson Health Care Systems Gets Up to $47.3 Million US Defense Logistics Agency Contract
MT
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Funds
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
MarketScreener Strategies
Most relevant news about JOHNSON & JOHNSON
09:29a
Johnson & Johnson Releases its 2022 Health for Humanity Report and We All Belong, 2022 ..
AQ
09:12a
Johnson & Johnson Releases 2022 Health for Humanity Report Demonstrating Progress Again..
AQ
03:55a
Johnson & Johnson Health Care Systems Gets Up to $47.3 Million US Defense Logistics Age..
MT
06/07
Johnson & Johnson : Janssen Submits Supplemental Biologics License Application to U.S. FDA..
PU
06/07
Janssen Submits Supplemental Biologics License Application to U.S. FDA Seeking Approval..
AQ
06/06
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
BU
06/06
Johnson & Johnson Submits Supplemental Biologics License Application to U.S. FDA Seekin..
CI
06/06
Advancing Multiple Shots On Clinical Goals, Coeptis Therapeutics Positions For A Busy V..
AQ
06/05
Johnson & Johnson : CARVYKTI® (ciltacabtagene autoleucel) Reduces Risk of Disease Progress..
PU
06/05
Johnson & Johnson Announces Long-Term Data from the Pivotal Phase 1/2 Majestec-1 Study
CI
06/05
The Janssen Pharmaceutical Companies of Johnson & Johnson Announces Results from the Ph..
CI
06/05
Johnson & Johnson Unit Recalls Impella Heart Pump, US FDA Designates Class 1 Recall Ord..
MT
06/05
Johnson & Johnson : Janssen Presents Longer-Term Data for TECVAYLI® (teclistamab-cqyv) Sho..
PU
06/05
Johnson & Johnson : Janssen Presents First-Ever Results from Dual Bispecific Combination S..
PU
06/05
Janssen Pharmaceutical - New Long-Term Data from the CHRYSALIS Study Show Median Progre..
AQ
More most relevant news
All news about JOHNSON & JOHNSON
09:29a
Johnson & Johnson Releases its 2022 Health for Humanity Report and We All Belong, 2022 ..
AQ
09:12a
Johnson & Johnson Releases 2022 Health for Humanity Report Demonstrating Progress Again..
AQ
03:55a
Johnson & Johnson Health Care Systems Gets Up to $47.3 Million US Defense Logistics Age..
MT
06/07
Johnson & Johnson : Janssen Submits Supplemental Biologics License Application to U.S. FDA..
PU
06/07
Indices: Flight to quality
06/07
Janssen Submits Supplemental Biologics License Application to U.S. FDA Seeking Approval..
AQ
06/06
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
BU
06/06
Johnson & Johnson Submits Supplemental Biologics License Application to U.S. FDA Seekin..
CI
06/06
Alkermes Gets Final Award in Janssen Pharmaceutica Arbitration; 2023 Adjusted EPS, Reve..
MT
06/06
Advancing Multiple Shots On Clinical Goals, Coeptis Therapeutics Positions For A Busy V..
AQ
More news
News in other languages on JOHNSON & JOHNSON
03:55a
Johnson & Johnson Health Care Systems obtient un contrat de 47,3 millions de dollars de..
06/06
Johnson & Johnson soumet à la FDA une demande d'autorisation de mise sur le marché supp..
06/06
Indizes: Fly to quality
06/06
J&J : des résultats prometteurs pour Carvykti
06/06
Alkermes reçoit la sentence finale dans l'arbitrage de Janssen Pharmaceutica ; révision..
06/06
J&J : présente des données à plus long terme sur Tecvayli
06/06
J&J : résultats encourageants pour le Balversa
06/06
Indices : Fly to quality avec une fusée
06/05
Rubrik, soutenue par Microsoft, engage des banques pour son introduction en bourse -sou..
06/05
Johnson & Johnson annonce les données à long terme de l'étude pivotale de phase 1/2 Maj..
More news
Analyst Recommendations on JOHNSON & JOHNSON
05/30
Kenvue Initiated at Outperform by RBC, Price Target Set at $29 as Firm Highlights Johns..
MT
04/20
UBS Adjusts Johnson & Johnson Price Target to $177 From $164, Maintains Neutral Rating
MT
04/19
Atlantic Equities Trims Price Target on Johnson & Johnson to $167 From $168, Keeps Neut..
MT
04/19
Bernstein Adjusts Price Target on Johnson & Johnson to $176 From $173, Keeps Market Per..
MT
04/19
Raymond James Adjusts Price Target on Johnson & Johnson to $181 From $185, Keeps Outper..
MT
More recommendations
Press releases
09:29a
Johnson & Johnson Releases its 2022 Health for Humanity Report and We All Belong, 2022 ..
AQ
09:12a
Johnson & Johnson Releases 2022 Health for Humanity Report Demonstrating Progress Again..
AQ
06/07
Johnson & Johnson : Janssen Submits Supplemental Biologics License Application to U.S. FDA..
PU
06/07
Janssen Submits Supplemental Biologics License Application to U.S. FDA Seeking Approval..
AQ
06/06
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
BU
More press releases
Powered by Scoopnest.com
Analysis
All about credit ratings
More Must read
Official Publications
05/03
SEC Filing 8K
04/28
SEC Filing 10Q-1
04/27
Minutes of the general assembly
04/18
SEC Filing 8K
04/18
1st quarter results
04/04
SEC Filing 8K
More Official Publications
Upcoming event on JOHNSON & JOHNSON
06/13/23
Goldman Sachs Global Healthcare Conference
Company calendar
Upcoming sector events
07/27/23
ROCHE HOLDING AG : Q2 2023 Earnings Release
08/01/23
MERCK & CO. : Q2 2023 Earnings Release
08/08/23
ELI LILLY AND COMPANY : Q2 2023 Earnings Release
08/10/23
NOVO NORDISK A/S : Q2 2023 Earnings Release
More events
Sector
Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals
Secure and increase the performance of your investments with our team of experts at your side.
Securing my Investments
Slave